Gallentes, Jerilyn .

HRN: 04-83-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
CEFUROXIME 1.5GM (VIAL)
10/05/2023
10/06/2023
IV
1.5 G
Once PTOR
For Stat CS
Waiting Final Action 
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/07/2023
IV
1.5g
PTOR
For CS For Breech
Waiting Final Action 
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/12/2023
IV
1.5g
Q8
LTCS
Waiting Final Action 
10/07/2023
CEFUROXIME 500MG (TAB)
10/07/2023
10/13/2023
PO
500mg
BID
Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: